课题基金 / 基金详情

Regulation of MyoD Post-Transcriptional Modifications

Regulation of MyoD Post-Transcriptional Modifications
MyoD 转录后修饰的调控
批准号:
6968392
负责人:
Vittorio Sartorelli
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Vittorio Sartorelli的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
MyoD is a transcriptional activator required for muscle-specific gene expression. Expression of exogenous MyoD in numerous terminally differentiated cell lineages ( neurons, adipocytes, skin cells, chondrocytes adn others) redirect their fates towards the skeletal muscle phenotype. Furthermore, MyoD - and the related Myf-5 protein- is essential for the formation of skeletal muscles in the animal. In order to activate transcription, MyoD requires the assistance of other interacting partners such as the p300/CBP and PCAf coactivators. We have previously reported that p300 and PCAF are nodal coactivators of the muscle specific transcription factor MyoD. MyoD is acetylated by PCAF and this results in an increased DNA-binding and transcriptional activity. Acetylation and deacetylation are in a dynamic equilibrium and our studies have identified a role for the histone deacetylases (HDACs) in controlling muscle differentiation. To uncover the molecular mechanisms and the effectors that mediate the HDACs activity, we have used small molecules to inhibit the enzymatic activity of HDACs in skeletal muscle cells and performed microarray temporal profiling. Furthermore, prompted by the observation that the redox state fluctuates in skeletal muscle in response to modification of oxygen tension and glucose uptake, we have analyzed the role of the NAD+-dependent deacetylase Sir2 in controlling muscle gene expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Metabolic Myopathy - Acid Maltase Deficiency
Control of Myogenesis and Regulation of MyoD Post-Transcriptional Modifications
Genetic Metabolic Myopathy - Acid Maltase Deficiency
Control of Myogenesis and Regulation of MyoD Post-Transcriptional Modifications
海外基金